Eric E Schadt1, John Lamb1, Xia Yang2, Jun Zhu1, Steve Edwards1, Debraj GuhaThakurta1, Solveig K Sieberts1, Stephanie Monks3, Marc Reitman4, Chunsheng Zhang1, Pek Yee Lum1, Amy Leonardson1, Rolf Thieringer5, Joseph M Metzger6, Liming Yang6, John Castle1, Haoyuan Zhu1, Shera F Kash7, Thomas A Drake8, Alan Sachs1
& Aldons J Lusis21
Rosetta Inpharmatics, Seattle, Washington
98109, USA.
2
Departments of Microbiology, Molecular Genetics, and Immunology; Medicine; and Human Genetics, University of California Los Angeles, Los Angeles, California
90095, USA.
3
Department of Statistics, Oklahoma State University, Stillwater, Oklahoma
74078, USA.
4
Department of Metabolic Disorders, Merck Research Laboratories, Rahway, New Jersey
07065, USA.
5
Department of Cardiovascular Disease, Merck Research Laboratories, Rahway, New Jersey
07065, USA.
6
Department of Pharmacology, Merck Research Laboratories, Rahway, New Jersey
07065, USA.
7
Deltagen, Inc., San Carlos, California
94070, USA.
8
Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California
90095, USA.
Correspondence should be addressed to Eric E Schadt eric_schadt@merck.com
